Biased receptor functionality versus biased agonism in G-protein-coupled receptors
- PMID: 30864350
- DOI: 10.1515/bmc-2018-0013
Biased receptor functionality versus biased agonism in G-protein-coupled receptors
Abstract
Functional selectivity is a property of G-protein-coupled receptors (GPCRs) by which activation by different agonists leads to different signal transduction mechanisms. This phenomenon is also known as biased agonism and has attracted the interest of drug discovery programs in both academy and industry. This relatively recent concept has raised concerns as to the validity and real translational value of the results showing bias; firstly biased agonism may vary significantly depending on the cell type and the experimental constraints, secondly the conformational landscape that leads to biased agonism has not been defined. Remarkably, GPCRs may lead to differential signaling even when a single agonist is used. Here we present a concept that constitutes a biochemical property of GPCRs that may be underscored just using one agonist, preferably the endogenous agonist. "Biased receptor functionality" is proposed to describe this effect with examples based on receptor heteromerization and alternative splicing. Examples of regulation of final agonist-induced outputs based on interaction with β-arrestins or calcium sensors are also provided. Each of the functional GPCR units (which are finite in number) has a specific conformation. Binding of agonist to a specific conformation, i.e. GPCR activation, is sensitive to the kinetics of the agonist-receptor interactions. All these players are involved in the contrasting outputs obtained when different agonists are assayed.
Keywords: GPCR heteromer; conformational landscape; cytocrin; dimer; effectors; oligomer; structure.
Similar articles
-
Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.Mol Pharmacol. 2015 Sep;88(3):579-88. doi: 10.1124/mol.115.099630. Epub 2015 Jul 1. Mol Pharmacol. 2015. PMID: 26134495 Free PMC article. Review.
-
Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective.Med Res Rev. 2014 Nov;34(6):1286-330. doi: 10.1002/med.21318. Epub 2014 May 5. Med Res Rev. 2014. PMID: 24796277 Review.
-
Biased G protein-coupled receptor agonism mediates Neu1 sialidase and matrix metalloproteinase-9 crosstalk to induce transactivation of insulin receptor signaling.Cell Signal. 2018 Mar;43:71-84. doi: 10.1016/j.cellsig.2017.12.006. Epub 2017 Dec 24. Cell Signal. 2018. PMID: 29277445
-
RGS proteins destroy spare receptors: Effects of GPCR-interacting proteins and signal deamplification on measurements of GPCR agonist potency.Methods. 2016 Jan 1;92:87-93. doi: 10.1016/j.ymeth.2015.08.011. Epub 2015 Aug 18. Methods. 2016. PMID: 26297537 Review.
-
Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential.Pharmacol Ther. 2019 Aug;200:148-178. doi: 10.1016/j.pharmthera.2019.05.006. Epub 2019 May 8. Pharmacol Ther. 2019. PMID: 31075355 Review.
Cited by
-
Biochemical and physiological insights into TRH receptor-mediated signaling.Front Cell Dev Biol. 2022 Sep 6;10:981452. doi: 10.3389/fcell.2022.981452. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36147745 Free PMC article. Review.
-
Expression of Melatonin and Dopamine D3 Receptor Heteromers in Eye Ciliary Body Epithelial Cells and Negative Correlation with Ocular Hypertension.Cells. 2020 Jan 8;9(1):152. doi: 10.3390/cells9010152. Cells. 2020. PMID: 31936298 Free PMC article.
-
The olfactory Olfr-78/51E2 receptor interacts with the adenosine A2A receptor. Effect of menthol and 1,8-cineole on A2A receptor-mediated signaling.Front Pharmacol. 2023 May 17;14:1108617. doi: 10.3389/fphar.2023.1108617. eCollection 2023. Front Pharmacol. 2023. PMID: 37266149 Free PMC article.
-
Methamphetamine Blocks Adenosine A2A Receptor Activation via Sigma 1 and Cannabinoid CB1 Receptors.Int J Mol Sci. 2021 Mar 9;22(5):2743. doi: 10.3390/ijms22052743. Int J Mol Sci. 2021. PMID: 33803075 Free PMC article.
-
Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases.Adv Exp Med Biol. 2021;1264:81-92. doi: 10.1007/978-3-030-57369-0_6. Adv Exp Med Biol. 2021. PMID: 33332005 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources